Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Clinical News

Tenofovir exalidex: Interim Ph IIa data

April 28, 2017 5:57 PM UTC

Interim data from 12 treatment-naïve patients with HBV infection in an open-label, Thai Phase IIa trial showed that once-daily 100 mg oral tenofovir exalidex led to a lower mean HBV viral load after 2...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article

BCIQ Target Profiles

Viral DNA polymerase